Malaria vaccine trial: Modest protection, good progress

Bremen JG, Alilio MS, Mills A: Conquering the intolerable burden of malaria: what’s new, what’s needed: a summary. Am J Trop Med Hyg 2004, 71(Suppl 2):1–15. Bojang KA, Milligan PJ, Pinder M, et al.: Efficacy of RTS,S/AS02A malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial. Lancet 2001, 358:1927–1934. Hay SI, Guerra CA, Tatem AJ, et al.: The global distribution and population at risk of malaria: past, present, and future. Lancet Infect Dis 2004, 4:327–336. Arrow KJ, Panosian CB, Gelband H: Saving Lives, Buying Time: Economics of Malaria Drugs in an Age of Resistance. Washington DC: The National Academies Press; 2004. Van de Perre P, Dedet JP: Vaccine efficacy: winning a battle (not war) against malaria. Lancet 2004, 364:1380–1382. Lyke KE, Dicko A, Kone A, et al.: Incidence of severe Plasmodium falciparum malaria as a primary endpoint for vaccine efficacy trials in Bandiagara, Mali. Vaccine 2004, 22:3169–3174.